CagriSema, which underperformed expectations in its first Phase 3 test, will be studied at different doses and for longer ...
A group of 18 colorectal cancer patients experienced complete remission after taking the experimental drug dostarlimab for ...
Pembrolizumab biosimilar is under clinical development by Bio-Thera Solutions and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase ...
Pembrolizumab is under clinical development by Merck and currently in Phase I for Kaposi Sarcoma. According to GlobalData, Phase I drugs for Kaposi Sarcoma have an 84% phase transition success rate ...
BOSTON - About 75 North Atlantic right whales, representing about 20% of the critically endangered species' population worldwide, have gathered in an area off the coast of New England. A aerial ...
The birth of antibody conjugator provides a new choice for its treatment. Antibody conjugator is a new type of biotherapeutic drug which is connected by monoclonal antibody via linker and cytotoxic ...
From 1971 to 1983, he lived in the west-end neighbourhood of Laurier Heights, shovelling walks for spending money, delivering the Edmonton Journal and graduating from St. Francis Xavier high ...
After a search and seizure of her apartment, Rodriguez-Lopez was arrested by search warrant on Jan. 9 and charged with reckless endangerment and practicing medicine without a license. New Haven ...
People have been keeping personal diaries for several millenniums, but free smartphone apps now let you capture much more than words. By J. D. Biersdorfer J.D. Biersdorfer, the Tech Tip columnist ...
with no new safety signals. Seven-year invasive disease–free survival was 80.8% with adjuvant T-DM1 and 67.1% with adjuvant trastuzumab, for an absolute difference of 13.7 percentage points.
A new morphometric fracture occurred in 22 women (6.3%) in the zoledronate–zoledronate group, in 23 women (6.6%) in the zoledronate–placebo group, and in 39 women (11.1%) in the placebo ...
An urgent health care workforce crisis is looming. In the United States, a country plagued by disparate health outcomes across its geographic regions, relative physician “deserts” (i.e ...